In the United States, women wearing breast implants have developed a rare form of cancer: Anaplastic large cell lymphoma has reported the Food and Drug administration (FDA) in a press release.
This cancer is not breast cancer but a type of non-Hodgkin lymphoma (cancer of the immune system).
As early as 2011, the FDA had identified a possible association between breast implants and the development of this cancer. Over the years, scientists have better identified the disease, but the exact number of cases “still difficult to determine due to the small number of reports worldwide and the lack of data on global sales of breast implants” stress the American health authorities.
However, the FDA says it has received a total of 414 reports of implant-related anaplastic large cell lymphoma, resulting in the deaths of 9 patients.
In France, a group of experts brought together by the National Cancer Institute (Inca) concluded that there is a clearly established link between the occurrence of anaplastic large cell lymphoma and the wearing of a breast implant. The National Agency for the Safety of Medicines and Health Products (ANSM), in collaboration with the Inca, has been actively investigating the possible causes of the appearance of this pathology ever since.
Read also :
Inflammation caused by discharge from a breast prosthesis
Breast implants: a low prosthesis rupture rate
